CD47 and breast cancer: Ex vivo molecular imaging of 25 BC samples (including two patients with bladder squamous cell carcinoma) illustrated that fluorescent tracer dependent on anti-CD47 targeting guidance attached to CD47 molecules on the surface of tumor cells.